Dow Inc vs Philip Morris International Inc. — how do they compare? Dow Inc trades at $28.52 (market cap $20.06B), while Philip Morris International Inc. trades at $199.9 (market cap $300.33B). The key difference: Philip Morris International Inc. is far larger — about 15× Dow Inc's market cap, and Dow Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals — on Pluang, investors hold Dow Inc for 82 Days and Philip Morris International Inc. for 85 Days on average.
| DOW | PM | |
|---|---|---|
Market Cap | $20.06B | $300.33B |
Volume | 7,817,231 | 3,935,700 |
Sector | Basic Materials | Consumer Staples |
52-Week High | $41.87 | $200.50 |
52-Week Low | $20.65 | $144.33 |
Typical Hold Time | 82 Days | 85 Days |
Enterprise Value | $35.75B | $343.44B |
Dividend Yield | 5.04% | 3.32% |
Signals from Pluang's Aura AI — not financial advice
DOW trades at $28.59, up 1.53% with bearish technical signals despite recent earnings beats. The chemical company faces fundamental challenges with negative net income margin (-3.13%) and declining revenue trends from $56.9B in 2022 to $40.0B in 2025. Analyst consensus shows mixed sentiment with 30.6% buy ratings but a $34.22 price target suggesting 20% upside. Recent dividend announcement of $0.35 provides income support while cash flow trends show operational improvement projected for 2026.
DOW presents a high-risk opportunity with significant valuation disconnect - low P/S ratio (0.48) contrasts with negative profitability metrics. The stock's appeal hinges on operational turnaround and margin recovery in 2026 projections. Key risks include persistent revenue declines, high debt levels (29.87% debt-to-asset ratio), and competitive pressures in chemicals sector. Current price near support at $28 creates tactical entry point for patient investors betting on management's execution.
Philip Morris International (PM) trades at $200.5, up 5.3% over 24 hours, with a bullish technical signal and strong earnings beats in Q1 and Q2 2026. The company shows robust fundamentals with 2025 revenue of $40.65B and net income of $11.35B, supported by a 67.48% gross margin. Recent news highlights expansion of smoke-free products like ZYN and IQOS, now over 40% of revenue, driving growth amid industry shifts.
Outlook is positive with analyst consensus at Buy (68%) and a $212.17 price target, though elevated P/E of 26.46 and regulatory risks in tobacco remain concerns. Earnings growth and smoke-free product adoption are key catalysts, but investors should monitor debt levels and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →